AKT, Akt |
protein kinase B |
AMPK |
adenosine monophosphate-activated protein kinase |
ATP |
adenosine 5′-triphosphate |
cAMP-PKA |
cyclic adenosine monophosphate protein kinase A |
CLP |
common lymphoid progenitor |
CP |
cyclophosphamide |
CR |
complete response |
CT |
chemotherapy |
DC |
dendritic cells |
DSR |
differential stress resistance |
DXR |
doxorubicin |
ECM |
extracellular matrix |
EGR1 |
early growth response 1 |
FMD |
fasting mimicking diet |
G-CSF |
granulocyte colony-stimulating factor |
HER2 |
human epidermal growth factor receptor 2 |
HO-1 |
heme oxygenase-1 |
HR+ |
hormone receptor positive |
ICD |
immunogenic cell death |
IFNγ |
interferon gamma |
IGF-1 |
insulin growth factor 1 |
IGF1R |
insulin growth factor 1 receptor |
M-CSF |
macrophage colony-stimulating factor |
MDSC |
myeloid derived suppressor cells |
mTOR |
mammalian target of rapamycin |
MTX |
mitoxantrone |
NK |
natural killer cell |
OX |
oxaliplatin |
PBMC |
peripheral blood mononuclear cell |
PD1 |
programmed cell death protein 1 |
PD-L1 |
programmed cell death protein 1 ligand |
PI3K |
phosphoinositide 3-kinase |
PR |
partial response |
QoL |
quality of life |
ROS |
reactive oxygen species |
RT |
radiation therapy |
STF |
short-term fasting |
TAC |
docetaxel/doxorubicin/cyclophosphamide |
TAM |
tumor associated macrophages |
TIL |
tumor infiltrating lymphocyte |
Tregs |
regulatory T cells |